Screener
West Pharmaceutical Services WST Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
FAQ
- What is West Pharmaceutical Services's free cash flow?
- West Pharmaceutical Services (WST) reported free cash flow of $80.8M in Q2 2026.
- How has West Pharmaceutical Services's free cash flow changed year-over-year?
- West Pharmaceutical Services's free cash flow decreased by 20.7% year-over-year, from $101.9M to $80.8M.
- What is the long-term trend for West Pharmaceutical Services's free cash flow?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's free cash flow has grown at a 9.1% compound annual growth rate (CAGR), from $330.6M to $468.9M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about West Pharmaceutical Services's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude